Search research articles
Contact Us
Filters
Showing results (241-250 of 251) with videos related to
Page
of 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2019
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study
O Türeci, U Sahin, H Schulze-Bergkamen, et al.
Journal of Cancer Research and Clinical Oncology
|
November 5, 2022
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
M Maßmann, J Treckmann, P Markus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2015
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
M Schuler, J C-H Yang, K Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 8, 2016
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
J C-H Yang, L V Sequist, C Zhou, et al.
ESMO Open
|
July 17, 2024
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity
I-A Mavroeidi, J Burghofer, S Kalbourtzis, et al.
ESMO Open
|
January 9, 2024
Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study
J Keyl, A Bucher, F Jungmann, et al.
Journal of Clinical Microbiology
|
April 4, 2000
Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer
G T Maine, R Stricker, M Schuler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2026
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)
N Frost, M Joosten, J Franzen, et al.
Journal of Child Neurology
|
March 21, 2012
Consensus statement on standard of care for congenital myopathies
Ching H Wang, James J Dowling, Kathryn North, et al.
Journal of Child Neurology
|
November 17, 2010
Consensus statement on standard of care for congenital muscular dystrophies
Ching H Wang, Carsten G Bonnemann, Anne Rutkowski, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 251) with videos related to
Sort By:
Page
of 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2019
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study
O Türeci, U Sahin, H Schulze-Bergkamen, et al.
Journal of Cancer Research and Clinical Oncology
|
November 5, 2022
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
M Maßmann, J Treckmann, P Markus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2015
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
M Schuler, J C-H Yang, K Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 8, 2016
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
J C-H Yang, L V Sequist, C Zhou, et al.
ESMO Open
|
July 17, 2024
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity
I-A Mavroeidi, J Burghofer, S Kalbourtzis, et al.
ESMO Open
|
January 9, 2024
Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study
J Keyl, A Bucher, F Jungmann, et al.
Journal of Clinical Microbiology
|
April 4, 2000
Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer
G T Maine, R Stricker, M Schuler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2026
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)
N Frost, M Joosten, J Franzen, et al.
Journal of Child Neurology
|
March 21, 2012
Consensus statement on standard of care for congenital myopathies
Ching H Wang, James J Dowling, Kathryn North, et al.
Journal of Child Neurology
|
November 17, 2010
Consensus statement on standard of care for congenital muscular dystrophies
Ching H Wang, Carsten G Bonnemann, Anne Rutkowski, et al.
Page
of 26